GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 66 days ( -0.540 % )
Last Price $5.59 0 %
High/ Low $5.59 - $5.59 0%
Chg 7 Days N/A $5.59 $5.59
Chg 30 Days N/A $5.59 $5.59
Chg 12 mos 27.92 % $4.37 $5.59
Trend - 3 mos 0.480 % Width: 0.545 %
Trend - 12 mos 53.61 % Width: 41.45 %
Pred. range - 3 mos $5.61 - $5.64 0.346 % - 0.89 %
Pred. range - 12 mos $6.36 - $8.99 13.73 % - 60.87 %
Short MA avg 3 mos Buy 2022-05-11 - 48 days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2022-05-13 - 46 days
Long MA avg 12 mos Sell 2022-02-28 - 99 days
Short/Long MA avg 12 mos Buy 2022-02-14 - 108 days
Pivot Short Sell 2022-07-19 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Antares Pharma

Antares Pharma Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; ZOMA-Jet and Twin-Jector, a needle-free a... ATRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT